Follow-up study in chronic active hepatitis after therapies with immunosuppressive drugs and tiopronin
- 13 Downloads
Follow-up studies were conducted in the patients with chronic active hepatitis treated 10 years ago with tiopronin (TP) or corticosteroids (CS). HB surface antigen (HBsAg) was measured in previously collected paraffin embedded liver sections by enzyme-labelled antibody technique. Of 72 cases examined, 15 cases were treated with TP only (8 cases) and combination with CS (7 cases), 38 cases with CS and 19 cases not treated with TP or CS (control group). Two deaths occurred in TP group (each 1 case in the single and combination treatments) in the 9th year due to bleeding of oesophageal varices in a chronic aggressive hepatitis (2B type) with HBsAg diffusely distributed in liver tissue. Two deaths were found in CS group and 4 in the control group. No significant difference was noted in the rehabilitation rate in HBsAg negative cases of TP group and CS group versus the control group. In the positive cases, the rehabilitation rate was found to be 66.7% in the CS group compared with 0% in the non-CS group, and each 3 cases out of 5 rehabilitated by the single and combination treatments with TP respectively.
Key Wordschronic active hepatitis chronic hepatitis corticosteroid therapy SH-compound therapy HBs antigen viral hepatitis type B liver diseases
Unable to display preview. Download preview PDF.
- 2).Ohta Y, Tsuji T, Nozaki H: Corticosteroid therapy in chronic hepatitis. Its reevaluation. Clin Immunol 7: 1145–1155, 1975 (Jpn)Google Scholar
- 3).Ohta Y, Tsuji T, Yoshida T, Yamada G, Kosaka K: Depolymerization of immunoglobulin M by α-mercaptopropionylglycine (Thiola) and its relation to rheumatoid factor in chronic liver diseases. Proceedings of the International Symposium on Thiola, Nov 25–26, 1970, Tokyo; 132–140Google Scholar
- 4).Kosaka K, Ohta Y, Tsuji T: A therapeutic effect of 2-mercaptopropionylglycine (MPG) on Australia antigen positive hepatitis. Proceedings of the Second International Symposium on Thiola, Dec 29–30, 1972, Jamaica; 79–88Google Scholar
- 13).Geal MG, Schoenfield LJ, Summerskill WHJ: Classification and treatment of chronic active liver disease. Gastroenterology 55: 724–729, 1968Google Scholar
- 14).Summerskill WHJ, Ammon HV, Baggenstoss AH: Treatment of chronic hepatitis, In: The Liver and Its Diseases: ed by T Schaffner, S Scherlock, CM Leevy, International Medical Book Corporation, New York, 216–226, 1973Google Scholar
- 15).Ohta Y, Tsuji T: Immunosuppressive therapy on chronic liver diseases. Autoimmune phenomena and effects of immunosuppressive drugs in progress of chronic hepatitis. Clin Immunol 2: 55–70, 1970 (Jpn)Google Scholar